| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Ryan D Wuebbles, Apurva Sarathy, Joe N Kornegay, Dean J Burki. Levels of α7 integrin and laminin-α2 are increased following prednisone treatment in the mdx mouse and GRMD dog models of Duchenne muscular dystrophy. Disease models & mechanisms. vol 6. issue 5. 2014-04-22. PMID:23846963. |
duchenne muscular dystrophy (dmd) is a fatal neuromuscular disease for which there is no cure and limited treatment options. |
2014-04-22 |
2023-08-12 |
mouse |
| Kristy Swiderski, Michelle Todorov, Stefan M Gehrig, Timur Naim, Annabel Chee, David I Stapleton, René Koopman, Gordon S Lync. Tranilast administration reduces fibrosis and improves fatigue resistance in muscles of mdx dystrophic mice. Fibrogenesis & tissue repair. vol 7. issue 1. 2014-02-03. PMID:24476069. |
novel treatments that can prevent or attenuate fibrosis have important clinical merit for dmd and related neuromuscular diseases. |
2014-02-03 |
2023-08-12 |
mouse |
| Mohammed T Taye. Deletion mutations in Duchenne muscular dystrophy (DMD) in Western Saudi children. Saudi journal of biological sciences. vol 17. issue 3. 2013-08-20. PMID:23961084. |
the disease is an x-linked neuromuscular diseases typically caused by disrupting (dmd) or non-disrupting (bmd) the reading frame in the dystrophin (dmd) gene. |
2013-08-20 |
2023-08-12 |
Not clear |
| Ruth McGowan, Benjamin R Challoner, Sarah Ross, Susan Holloway, Shelagh Joss, Douglas Wilcox, Simon T Holden, John Tolmie, Cheryl Longma. Results of Duchenne muscular dystrophy family screening in practice: leaks rather than cascades? Clinical genetics. vol 83. issue 2. 2013-08-05. PMID:22428906. |
duchenne muscular dystrophy (dmd) is a progressive neuromuscular disease caused by mutations in the gene that encodes the protein dystrophin. |
2013-08-05 |
2023-08-12 |
Not clear |
| Gregory T Carter, Nanette C Joyce, Allison L Abresch, Amanda E Smith, Gregg K VandeKeif. Using palliative care in progressive neuromuscular disease to maximize quality of life. Physical medicine and rehabilitation clinics of North America. vol 23. issue 4. 2013-05-22. PMID:23137745. |
this article discusses the role of palliative care in the treatment pathway of patients with progressive neuromuscular disease (ndm), including amyotrophic lateral sclerosis and duchenne muscular dystrophy (dmd). |
2013-05-22 |
2023-08-12 |
Not clear |
| Sarah K Gray, Meghan E McGee-Lawrence, Jennifer L Sanders, Keith W Condon, Chung-Jui Tsai, Seth W Donahu. Black bear parathyroid hormone has greater anabolic effects on trabecular bone in dystrophin-deficient mice than in wild type mice. Bone. vol 51. issue 3. 2012-12-17. PMID:22584007. |
duchenne muscular dystrophy (dmd) is an x-linked neuromuscular disease that has deleterious consequences in muscle and bone, leading to decreased mobility, progressive osteoporosis, and premature death. |
2012-12-17 |
2023-08-12 |
mouse |
| R Renjini, N Gayathri, A Nalini, M M Srinivas Bharat. Oxidative damage in muscular dystrophy correlates with the severity of the pathology: role of glutathione metabolism. Neurochemical research. vol 37. issue 4. 2012-11-26. PMID:22219131. |
muscular dystrophies (mds) such as duchenne muscular dystrophy (dmd), sarcoglycanopathy (sgpy) and dysferlinopathy (dysfy) are recessive genetic neuromuscular diseases that display muscle degeneration. |
2012-11-26 |
2023-08-12 |
mouse |
| Nevenka Juretić, Gonzalo Jorquera, Pablo Caviedes, Enrique Jaimovich, Nora Rivero. Electrical stimulation induces calcium-dependent up-regulation of neuregulin-1β in dystrophic skeletal muscle cell lines. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology. vol 29. issue 5-6. 2012-11-08. PMID:22613991. |
duchenne muscular dystrophy (dmd) is a neuromuscular disease originated by reduced or no expression of dystrophin, a cytoskeletal protein that provides structural integrity to muscle fibres. |
2012-11-08 |
2023-08-12 |
human |
| Justin M Percival, Nicholas P Whitehead, Marvin E Adams, Candace M Adamo, Joseph A Beavo, Stanley C Froehne. Sildenafil reduces respiratory muscle weakness and fibrosis in the mdx mouse model of Duchenne muscular dystrophy. The Journal of pathology. vol 228. issue 1. 2012-10-09. PMID:22653783. |
pde5 inhibitors serve to amplify no signalling that is attenuated in many neuromuscular diseases including dmd. |
2012-10-09 |
2023-08-12 |
mouse |
| Shin'ichi Taked. [Exon-skipping therapy for Duchenne muscular dystrophy]. Rinsho shinkeigaku = Clinical neurology. vol 51. issue 11. 2012-09-18. PMID:22277414. |
clinical trials of exon 51 skipping for dmd patients is now going in our country and application of antisense strategy to other hereditary neuromuscular diseases is largely expected. |
2012-09-18 |
2023-08-12 |
mouse |
| Roxanna M Bendixen, Claudia Senesac, Donovan J Lott, Krista Vandenborn. Participation and quality of life in children with Duchenne muscular dystrophy using the International Classification of Functioning, Disability, and Health. Health and quality of life outcomes. vol 10. 2012-07-18. PMID:22545870. |
dmd is one of the most devastating genetically linked neuromuscular diseases for which there is currently no cure. |
2012-07-18 |
2023-08-12 |
Not clear |
| Nabeel Ahmad, Ian Welch, Robert Grange, Jennifer Hadway, Savita Dhanvantari, David Hill, Ting-Yim Lee, Lisa M Hoffma. Use of imaging biomarkers to assess perfusion and glucose metabolism in the skeletal muscle of dystrophic mice. BMC musculoskeletal disorders. vol 12. 2012-04-19. PMID:21639930. |
duchenne muscular dystrophy (dmd) is a severe neuromuscular disease that affects 1 in 3500 boys. |
2012-04-19 |
2023-08-12 |
mouse |
| John B Bodensteiner, Yu-Tze N. Ethical considerations in paediatric neurology: neuromuscular disease and epilepsy. Journal of paediatrics and child health. vol 47. issue 9. 2012-02-01. PMID:21951440. |
for neuromuscular disease, the example of duchenne muscular dystrophy (dmd) with regards to genetic testing, relatively early wheelchair placement and individualised invasive ventilation is discussed. |
2012-02-01 |
2023-08-12 |
human |
| Davide Cacchiarelli, Ivano Legnini, Julie Martone, Valentina Cazzella, Adele D'Amico, Enrico Bertini, Irene Bozzon. miRNAs as serum biomarkers for Duchenne muscular dystrophy. EMBO molecular medicine. vol 3. issue 5. 2011-08-09. PMID:21425469. |
even though creatine kinase (ck) blood levels have been utilized as diagnostic markers of several neuromuscular diseases, including dmd, we demonstrate that they correlate less well with the disease severity. |
2011-08-09 |
2023-08-12 |
mouse |
| A T J M Helderman-van den Enden, J C van den Bergen, M H Breuning, J J G M Verschuuren, A Tibben, E Bakker, H B Ginjaa. Duchenne/Becker muscular dystrophy in the family: have potential carriers been tested at a molecular level? Clinical genetics. vol 79. issue 3. 2011-05-24. PMID:21070212. |
duchenne muscular dystrophy (dmd) is the most common inherited neuromuscular disease. |
2011-05-24 |
2023-08-12 |
Not clear |
| Thomas Sejerson, Kate Bushb. Standards of care for Duchenne muscular dystrophy: brief TREAT-NMD recommendations. Advances in experimental medicine and biology. vol 652. 2010-04-02. PMID:20225016. |
a worldwide effort is underway to generate care guidelines for dmd, which involves the centre for disease control in the usa and the treat-nmd network of excellence for neuromuscular diseases in europe. |
2010-04-02 |
2023-08-12 |
Not clear |
| Benjamin Koo, Jacqueline Montes, Viktor Gamarnik, Keith Yeager, Jonathan Marra, Sally Dunaway, Megan Montgomery, Darryl C De Vivo, Nancy Strauss, Elisa Konofagou, Petra Kaufmann, Barclay Morriso. Design and evaluation of a hybrid passive and active gravity neutral orthosis (GNO). Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference. vol 2009. 2010-03-25. PMID:19963513. |
neuromuscular diseases (nmd), including spinal muscular atrophy (sma) and duchenne muscular dystrophy (dmd), result in progressive muscular weakness that often leaves patients functionally dependent on caregivers for many activities of daily living (adl) such as eating, bathing, grooming (touching the face and head), reaching (grabbing for objects), and dressing. |
2010-03-25 |
2023-08-12 |
Not clear |
| L B López-Hernández, N A Vázquez-Cárdenas, E Luna-Padró. [Duchenne muscular dystrophy: current aspects and perspectives on treatment]. Revista de neurologia. vol 49. issue 7. 2009-12-16. PMID:19774532. |
duchenne muscular dystrophy (dmd) is a severe neuromuscular disease of genetic origin that affects male children. |
2009-12-16 |
2023-08-12 |
Not clear |
| Jainn-Jim Lin, Mao-Sheng Hwang, Shao-Hsuan Hsia, Hung-Tao Chung, Yu-Sheng Chang, Kuang-Lin Li. Pericardial effusion with cardiac tamponade as a cardiac manifestation of Duchenne muscular dystrophy. Muscle & nerve. vol 40. issue 3. 2009-10-06. PMID:19623636. |
duchenne muscular dystrophy (dmd) is the most common hereditary neuromuscular disease in children. |
2009-10-06 |
2023-08-12 |
Not clear |
| Raffaella Willmann, Stefanie Possekel, Judith Dubach-Powell, Thomas Meier, Markus A Rueg. Mammalian animal models for Duchenne muscular dystrophy. Neuromuscular disorders : NMD. vol 19. issue 4. 2009-07-28. PMID:19217290. |
duchenne muscular dystrophy (dmd) is a fatal neuromuscular disease that affects boys and leads to early death. |
2009-07-28 |
2023-08-12 |
Not clear |